S1P-S1PR3-RAS promotes the progression of S1PR3hi TAL1+ T-cell acute lymphoblastic leukemia that can be effectively inhibited by an S1PR3 antagonist.
Zhu D, Jiang T, Ma D, Zhang H, Zhang J, Lv W, Gong M, Wang H, Liu Z, Su H, Zeng L, Liu S, Tang S, Yang B, Tshavuka FI, Fu G, Liu Z, Peng D, Liu H, Yan Z, Cao Z, Zhao H, He TC, Yu J, Shu Y, Zou L.
Zhu D, et al. Among authors: zhang j, zhang h.
Leukemia. 2023 Oct;37(10):1982-1993. doi: 10.1038/s41375-023-02000-0. Epub 2023 Aug 17.
Leukemia. 2023.
PMID: 37591940